Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide vs prednisone for erosive oral lichen planus
ChiCTR2300078677Phase 4Recruiting
- Sponsor
- West China Hospital of Stomatology, Sichuan University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of thalidomide in oral lichen planus (OLP) (2 arms), sponsored by West China Hospital of Stomatology, Sichuan University. Primary endpoints: erosive lesion size and pain level. Started Dec 2023; status: recruiting.
02
Drugs
thalidomide
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on ChiCTR2300078677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078677.